BTIG Research Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its price target cut by equities researchers at BTIG Research from $130.00 to $110.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s target price indicates a potential upside of 42.65% from the stock’s previous close.

Several other brokerages have also weighed in on HQY. The Goldman Sachs Group lowered HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price on the stock. in a research report on Friday, January 9th. Barclays initiated coverage on shares of HealthEquity in a report on Monday, December 8th. They set an “overweight” rating and a $118.00 price objective on the stock. Raymond James Financial set a $100.00 target price on shares of HealthEquity in a research report on Tuesday. Citizens Jmp set a $122.00 price target on shares of HealthEquity in a research report on Thursday, December 4th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $120.00 price objective on shares of HealthEquity in a report on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $115.60.

HealthEquity Trading Up 3.7%

HQY opened at $77.11 on Tuesday. HealthEquity has a 12 month low of $72.76 and a 12 month high of $116.65. The stock has a market capitalization of $6.59 billion, a price-to-earnings ratio of 35.37, a PEG ratio of 0.93 and a beta of 0.24. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The business has a fifty day moving average price of $87.28 and a 200 day moving average price of $91.84.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter last year, the company earned $0.78 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Sell-side analysts expect that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This trade represents a 19.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently made changes to their positions in HQY. Vanguard Group Inc. boosted its holdings in HealthEquity by 2.9% during the third quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock worth $828,883,000 after buying an additional 243,549 shares in the last quarter. Wasatch Advisors LP increased its stake in HealthEquity by 4.5% in the 4th quarter. Wasatch Advisors LP now owns 6,589,646 shares of the company’s stock valued at $603,677,000 after purchasing an additional 281,971 shares in the last quarter. Geode Capital Management LLC raised its holdings in HealthEquity by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock worth $201,685,000 after purchasing an additional 5,671 shares during the last quarter. Westfield Capital Management Co. LP raised its holdings in HealthEquity by 13.7% during the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after purchasing an additional 235,794 shares during the last quarter. Finally, William Blair Investment Management LLC purchased a new stake in HealthEquity during the fourth quarter worth $169,956,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity News Summary

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Reported record Q4 results and standout fiscal‑2026 sales metrics (HSAs, HSA assets, total accounts); the company reaffirmed its fiscal 2026 and 2027 outlook and published an updated HSA cash repricing schedule — a direct operational/cash‑flow positive update for the HSA business. Read More.
• Positive Sentiment: Raised FY‑2026 EPS guidance to $3.870–$3.950 versus consensus ~$3.69 — this gap to the Street helps justify today’s upward move and supports valuation multiple expansion if execution continues. Read More.
• Positive Sentiment: Analyst commentary and strategy pieces highlight durable HSA volume growth, AI‑driven efficiency gains, and recurring revenue characteristics — factors underpinning long‑term growth stories and investor confidence. Read More.
• Neutral Sentiment: Analyst roundup: coverage from eight analysts provides mixed near‑term views but overall stays constructive; watch for updated consensus estimates and any changes to ratings following the company release. Read More.
• Negative Sentiment: BTIG trimmed its price target from $130 to $110 (still a Buy) — a lower PT reduces upside expectations from some institutional buyers and signals more modest margin for error. Read More.
• Negative Sentiment: Operational risk reminder: analysts flag data security and privacy threats as a meaningful risk for custodial HSA platforms; any adverse incident could meaningfully hurt sentiment and valuation. Read More.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.